These exosomes demonstrate potential in delivering therapeutic agents such as low-density lipoprotein receptor (LDLR) mRNA for familial hypercholesterolemia, highlighting their biocompatibility and utility in drug delivery systems [61,62,117]. The gene discussed is LDLR; the disease is familial hypercholesterolemia.